Investing Profile

Elliott Sigal

InvestorAngel
Senior Advisor at New Enterprise Associates (NEA)
Princeton, New Jersey
Photo of Elliott Sigal, Advisor at New Enterprise Associates (NEA)

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
University of Chicago Network
135 CONNECTIONS
New Enterprise Associates (NEA) Network
95 CONNECTIONS
Purdue University Network
82 CONNECTIONS
Purdue University Network
82 CONNECTIONS
Purdue University Network
82 CONNECTIONS
cb
$5K - $50K
$25K
2
$6.2B
CompanyStageDateRound SizeTotal Raised
Mersana Therapeutics
Series BMar 2015$35M
$110M
Co-investors: David Parkinson (ESSA Pharma), Sara Nayeem (Avoro Ventures)
Surface Oncology
Series AJan 2015$35M
$35M
Co-investors: Michael Gladstone (Atlas Venture)
Board Member Alnylam Pharmaceuticals2022 - Present
Board Member Vir Biotechnology, Inc.2020 - Present
Co-Chair, Scientific Advisory Board Amgen2015 - Present
Board Member Adaptimmune US2014 - Present
Chief Scientific Officer and Executive Vice President Bristol Myers SquibbPresent
Board Member Bristol Myers SquibbPresent
Board Member AdaptimmunePresent
Board Member Surface Oncology Inc.2018 - 2023
Senior Advisor New Enterprise Associates (NEA)2014 - 2023
Board Member Melanoma Research Alliance2013 - 2023
Board Member Spark Therapeutics, Inc.2014 - 2019
Board Member Bristol-Myers Squibb2011 - 2013
Chief Scientific Officer and Executive Vice President Bristol-Myers Squibb2004 - 2013
University of Chicago Doctor of Medicine (M.D.) Medicine
Purdue University Doctor of Philosophy (Ph.D.) Industrial Engineering
Purdue University Bachelor of Science (BS) Industrial Engineering
Purdue University Master of Science (MS) Industrial Engineering
Sign in with Google →
Sign in with Google →